RBL2 and breast neoplasm: This result is in agreement with Udler et al., who reported a dose-dependent association between the rs3803662 risk allele with increased expression of RBL2 mRNA expression in lymphocytes; however, an association between the rs3803662 genotype and RBL2 mRNA expression in 77 breast tumours was not seen[13].